Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

PRISM BioLab

PRISM BioLab

206A · TSE · Pharmaceutical

Financials Company only

Revenue¥677m+121.6% year on yearCompany only · FY9/25

Ordinary profit−¥748mCompany only · FY9/25

Performance over time

Revenue
¥58.8mFY9/21
¥554mFY9/22
¥113mFY9/23
¥306mFY9/24
¥677mFY9/25
Ordinary profit
−¥154mFY9/21
¥78.7mFY9/22
−¥498mFY9/23
−¥832mFY9/24
−¥748mFY9/25
Op. cash flow
—FY9/21
¥103mFY9/22
−¥514mFY9/23
¥150mFY9/24
−¥1.47bnFY9/25

People & pay

Employees35 peopleFY9/25

Average salary¥9.46mFY9/25

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitEPSTotal assetsNet assetsOp. cash flow
FY9/25¥677.3m+121.6% year on year−¥748.3m−¥22.82¥3.09bn¥2.71bn−¥1,468m
FY9/24¥305.6m+170.6% year on year−¥831.5m−¥33.53¥4.53bn¥3.50bn¥150m
FY9/23¥112.9m−79.6% year on year−¥497.6m−¥19.09¥1.21bn¥1.15bn−¥514m
FY9/22¥554.4m+842.8% year on year¥78.7m¥2.67¥1.74bn¥1.67bn¥103m
FY9/21¥58.8m−¥153.7m−¥1,556.87¥1.51bn¥1.09bn—

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100XCIN · Japan GAAP. Each figure's years come from one report's five-year summary.